David Reiner‐Link

536 total citations
29 papers, 418 citations indexed

About

David Reiner‐Link is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, David Reiner‐Link has authored 29 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in David Reiner‐Link's work include Mast cells and histamine (15 papers), Receptor Mechanisms and Signaling (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (7 papers). David Reiner‐Link is often cited by papers focused on Mast cells and histamine (15 papers), Receptor Mechanisms and Signaling (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (7 papers). David Reiner‐Link collaborates with scholars based in Germany, Poland and United States. David Reiner‐Link's co-authors include Holger Stark, Katarzyna Kieć‐Kononowicz, Dorota Łażewska, Nakisa Ghamari, Omid Zarei, Maryam Hamzeh‐Mivehroud, Siavoush Dastmalchi, Nermin Eissa, Bassem Sadek and Petrilla Jayaprakash and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

David Reiner‐Link

29 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reiner‐Link Germany 13 218 133 83 69 64 29 418
Kirsten L. Miller United States 10 191 0.9× 76 0.6× 100 1.2× 28 0.4× 42 0.7× 12 386
Marina I. Strakhova United States 12 363 1.7× 393 3.0× 51 0.6× 28 0.4× 37 0.6× 21 713
Shilina Roman United Kingdom 15 152 0.7× 71 0.5× 97 1.2× 36 0.5× 8 0.1× 22 450
Pradeep Jayarajan India 14 201 0.9× 26 0.2× 140 1.7× 49 0.7× 58 0.9× 56 521
Shalini Dogra India 15 346 1.6× 46 0.3× 60 0.7× 24 0.3× 52 0.8× 28 617
Jen Barnes United Kingdom 11 218 1.0× 32 0.2× 63 0.8× 32 0.5× 67 1.0× 15 501
Shiu‐Hwa Yeh Taiwan 9 240 1.1× 33 0.2× 38 0.5× 57 0.8× 188 2.9× 14 594
Andy Billinton United Kingdom 13 235 1.1× 83 0.6× 222 2.7× 17 0.2× 49 0.8× 22 673
Cornelia Dorner‐Ciossek Germany 19 412 1.9× 20 0.2× 205 2.5× 46 0.7× 109 1.7× 41 817
Hiroko Tsunekawa Japan 11 135 0.6× 23 0.2× 110 1.3× 15 0.2× 45 0.7× 13 496

Countries citing papers authored by David Reiner‐Link

Since Specialization
Citations

This map shows the geographic impact of David Reiner‐Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reiner‐Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reiner‐Link more than expected).

Fields of papers citing papers by David Reiner‐Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reiner‐Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reiner‐Link. The network helps show where David Reiner‐Link may publish in the future.

Co-authorship network of co-authors of David Reiner‐Link

This figure shows the co-authorship network connecting the top 25 collaborators of David Reiner‐Link. A scholar is included among the top collaborators of David Reiner‐Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reiner‐Link. David Reiner‐Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sgambellone, Silvia, Mohammad A. Khanfar, Annika Frank, et al.. (2024). Histamine H3 receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection. Biomedicine & Pharmacotherapy. 180. 117454–117454. 1 indexed citations
2.
3.
Reiner‐Link, David, et al.. (2022). Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors. Bioorganic & Medicinal Chemistry. 78. 117132–117132. 3 indexed citations
4.
Reiner‐Link, David, et al.. (2021). Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation. Bioorganic & Medicinal Chemistry. 50. 116462–116462. 7 indexed citations
5.
Godyń, Justyna, Paula Zaręba, Dorota Łażewska, et al.. (2021). Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease. Bioorganic Chemistry. 114. 105129–105129. 14 indexed citations
6.
Kuder, Kamil, et al.. (2021). Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties. Molecules. 26(8). 2300–2300. 3 indexed citations
7.
Łażewska, Dorota, Agnieszka Olejarz‐Maciej, David Reiner‐Link, et al.. (2020). Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors. International Journal of Molecular Sciences. 21(10). 3411–3411. 16 indexed citations
8.
Reiner‐Link, David, et al.. (2020). Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies. European Journal of Medicinal Chemistry. 191. 112150–112150. 2 indexed citations
9.
Grosicki, Marek, Maristella Adami, Cristina Micheloni, et al.. (2020). Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 – Triazine and 1H-indole like derivatives against the human histamine H4 receptor. European Journal of Pharmacology. 890. 173611–173611. 6 indexed citations
10.
Eissa, Nermin, Sheikh Azimullah, Petrilla Jayaprakash, et al.. (2020). The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice. International Journal of Molecular Sciences. 21(11). 3996–3996. 35 indexed citations
11.
Reiner‐Link, David, et al.. (2020). Epigenetics meets GPCR: inhibition of histone H3 methyltransferase (G9a) and histamine H3 receptor for Prader–Willi Syndrome. Scientific Reports. 10(1). 13558–13558. 7 indexed citations
12.
Reiner‐Link, David, et al.. (2019). Profiling of LINS01 compounds at human dopamine D2 and D3 receptors. Journal of Chemical Sciences. 132(1). 7 indexed citations
13.
Ghamari, Nakisa, Omid Zarei, José‐Antonio Arias‐Montaño, et al.. (2019). Histamine H3 receptor antagonists/inverse agonists: Where do they go?. Pharmacology & Therapeutics. 200. 69–84. 54 indexed citations
14.
Reiner‐Link, David & Holger Stark. (2019). Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring. European Journal of Pharmacology. 848. 112–120. 14 indexed citations
15.
Ghamari, Nakisa, Siavoush Dastmalchi, Omid Zarei, et al.. (2019). In silico and in vitro studies of two non‐imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes. Chemical Biology & Drug Design. 95(2). 279–290. 12 indexed citations
16.
Khanfar, Mohammad A., David Reiner‐Link, Stefanie Hagenow, & Holger Stark. (2018). Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands. Bioorganic & Medicinal Chemistry. 26(14). 4034–4046. 17 indexed citations
17.
Łażewska, Dorota, Stefanie Hagenow, Szczepan Mogilski, et al.. (2018). Novel naphthyloxy derivatives – Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation. Bioorganic & Medicinal Chemistry. 26(9). 2573–2585. 24 indexed citations
18.
Mietlicki‐Baase, Elizabeth G., Tito Borner, David Reiner‐Link, et al.. (2018). A vitamin B12 conjugate of exendin‐4 improves glucose tolerance without associated nausea or hypophagia in rodents. Diabetes Obesity and Metabolism. 20(5). 1223–1234. 30 indexed citations
19.
Ghamari, Nakisa, Omid Zarei, David Reiner‐Link, et al.. (2018). Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects. Chemical Biology & Drug Design. 93(5). 832–843. 24 indexed citations
20.
Mietlicki‐Baase, Elizabeth G., Lauren E. McGrath, Kieran Koch‐Laskowski, et al.. (2017). Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance. Physiology & Behavior. 173. 9–14. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten L. Miller Breakdown of academic impact, for papers by Marina I. Strakhova Breakdown of academic impact, for papers by Shilina Roman Breakdown of academic impact, for papers by Pradeep Jayarajan Breakdown of academic impact, for papers by Shalini Dogra Breakdown of academic impact, for papers by Jen Barnes Breakdown of academic impact, for papers by Shiu‐Hwa Yeh Breakdown of academic impact, for papers by Andy Billinton Breakdown of academic impact, for papers by Cornelia Dorner‐Ciossek Breakdown of academic impact, for papers by Hiroko Tsunekawa
Rankless by CCL
2026